Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $8.46, but opened at $8.04. Oxford BioMedica shares last traded at $8.04, with a volume of 125 shares traded.
Oxford BioMedica Stock Performance
The firm’s 50-day simple moving average is $8.27 and its two-hundred day simple moving average is $6.57. The company has a debt-to-equity ratio of 3.08, a quick ratio of 1.67 and a current ratio of 1.89.
Oxford BioMedica Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Recommended Stories
- Five stocks we like better than Oxford BioMedica
- Conference Calls and Individual Investors
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Kraken Robotics Stock Exploded 1,000%—Now Wall Street Is Paying Attention
- Following Congress Stock Trades
- Kroger Stock Analysis: Digital Pivot, Dividend Safety & 2026 Growth Plan
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
